| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.13 | 7e-05 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0001 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0001 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.16 | 0.0002 |
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0002 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0002 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.1 | 0.0003 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0004 |